Trials / Conditions / Fetal and Neonatal Alloimmune Thrombocytopenia
Fetal and Neonatal Alloimmune Thrombocytopenia
5 registered clinical trials studyying Fetal and Neonatal Alloimmune Thrombocytopenia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | Phase 2 Study on the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloim NCT06435845 | Rallybio | Phase 2 |
| Completed | Study to Assess the Occurrence of HPA-1a Alloimmunization in Women With Higher Risk for Fetal and Neonatal All NCT05345561 | Rallybio | — |
| Unknown | Neurodevelopmental Outcome After Fetal Neonatal AlloImmune Thrombocytopenia NCT04529382 | Leiden University Medical Center | — |
| Completed | Kinetics of Blood Platelets Transfused to Healthy Subjects NCT03561909 | Prophylix Pharma AS | N/A |
| Completed | Towards Routine HPA-screening In Pregnancy to Prevent FNAIT NCT04067375 | Leiden University Medical Center | — |